DailyDoctor Archive Specialties Get app
Back to the 14 October 2026 edition

Practice changer · 06 of 06

In suspected Crohn's disease, use calprotectin to decide who needs endoscopy

Consider faecal calprotectin to guide referral for endoscopy in suspected Crohn's disease, and exclude intestinal tuberculosis before immunosuppression.

An American Family Physician review, dated August, sets out diagnosis and management of Crohn's disease for family physicians. Diarrhoea, abdominal pain, fatigue, weight loss and fever are common, and children may present with slowed growth or delayed puberty. Initial evaluation includes endoscopy and cross-sectional imaging, and faecal calprotectin helps decide whether ileocolonoscopy and imaging are needed in uncertain cases.

The review notes that mucosal inflammation can persist after symptoms settle and inflammatory markers normalise, so objective monitoring matters. Patients should be tested for iron, vitamin D, folate and vitamin B12 deficiency. Because colon cancer risk is raised, most guidelines advise colonoscopy 8 years after symptom onset, with monitoring depending on other risk factors.

For mild to moderate disease the review lists budesonide, sulfasalazine and dietary modification to induce remission, and for moderate to severe disease corticosteroids or biologic therapy with or without an immunomodulator. In India, intestinal tuberculosis is an important mimic, so tuberculosis should be considered before starting immunosuppression. This is a narrative review, not a trial.

  • Use faecal calprotectin to help decide who needs ileocolonoscopy and imaging when the picture is uncertain
  • Check iron, vitamin D, folate and vitamin B12 in patients with confirmed disease
  • Do not rely on symptoms alone to judge remission, since inflammation can persist
  • Think of intestinal tuberculosis as a mimic and exclude it before immunosuppression
  • Plan surveillance colonoscopy around 8 years after symptom onset, as most guidelines advise

Why it matters

It gives a practical, non-invasive step for deciding who needs invasive investigation, in a condition often labelled as irritable bowel.

Don't overread it

A narrative review summarises existing guidance; it is not new trial evidence and does not change any guideline.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

preventionscreeningpcdiagnosticsmsk

Tomorrow morning, before your first patient

One edition a day for family medicine, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app